Zinc & prostate cancer
This article was originally published in The Tan Sheet
Executive Summary
Chronic zinc oversupply "may play a role in prostate carcinogenesis," according to data compiled by Michael Leitzmann, MD, National Institutes of Health, et al., appearing in July 2 Journal of the National Cancer Institute. Researchers found that "compared with nonusers, men who consumed more than 100 mg per day of supplemental zinc had a relative risk of advanced prostate cancer of 2.29, and men who took supplemental zinc for ten or more years" had a relative risk of 2.37. Leitzmann et al. studied data collected from 46,974 men in the Health Professionals Follow-Up Study between 1986 and 2000. Residual confounding by supplemental calcium intake or by an unmeasured correlate of zinc supplement use could explain these findings, researchers suggest, although they recommend further investigation...
You may also be interested in...
Zinc and prostate cancer
A study finds "no statistically significant association" between zinc supplementation and prostate cancer risk, according to a letter in the Journal of the National Cancer Institute by the study authors. Ellen Chang, Karolinska Institute, Stockholm, et al., conducted a population-based case-control study among 1,499 prostate cancer patients and 1,130 control subjects, finding no increase in prostate cancer risk arising from supplemental zinc use categorized by frequency, duration or cumulative exposure. The results contradict a 2003 JNCI study that reported a greater risk of prostate cancer among users of supplemental zinc (1"The Tan Sheet" July 14, 2003, In Brief)...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.